90 related articles for article (PubMed ID: 32912379)
1. Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali.
Diarra B; Decroo T; Somboro A; Coulibaly G; Tolofoudie M; Kone M; Degoga B; Diallo F; Togo ACG; Sanogo M; Sarro YS; Cisse AB; Kodio O; Baya B; Kone A; Maiga M; Dao S; Maiga II; Murphy RL; Siddiqui S; Toloba Y; Konate B; Diakite M; Doumbia S; Van Deun A; Rigouts L; Diallo S; de Jong BC
Int J Tuberc Lung Dis; 2020 Aug; 24(8):763-769. PubMed ID: 32912379
[No Abstract] [Full Text] [Related]
2. Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali.
Diarra B; Kone M; Togo ACG; Sarro YDS; Cisse AB; Somboro A; Degoga B; Tolofoudie M; Kone B; Sanogo M; Baya B; Kodio O; Maiga M; Belson M; Orsega S; Krit M; Dao S; Maiga II; Murphy RL; Rigouts L; Doumbia S; Diallo S; de Jong BC
PLoS One; 2018; 13(12):e0208603. PubMed ID: 30540823
[TBL] [Abstract][Full Text] [Related]
3. Screening new tuberculosis patients in Mali for rifampicin resistance at 2months.
Diarra B; Cissé AB; Kodio O; Sanogo M; Baya B; Togo AC; Somboro A; Tolofoudié M; Degoga B; Keita ML; Diallo F; Nguiakam N; Coulibaly G; Bane S; Sarro YD; Doumbia S; Murphy RL; Diallo S; Dejong BC
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S42-S43. PubMed ID: 28043602
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
5. Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis.
Van Deun A; Maug AK; Hossain A; Gumusboga M; de Jong BC
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1174-9. PubMed ID: 22747903
[TBL] [Abstract][Full Text] [Related]
6. The New Xpert MTB/RIF Ultra: Improving Detection of
Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
[TBL] [Abstract][Full Text] [Related]
7. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.
de Vos M; Derendinger B; Dolby T; Simpson J; van Helden PD; Rice JE; Wangh LJ; Theron G; Warren RM
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976588
[TBL] [Abstract][Full Text] [Related]
9. Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
Chiang TY; Fan SY; Jou R
PLoS One; 2018; 13(7):e0200755. PubMed ID: 30011319
[TBL] [Abstract][Full Text] [Related]
10. Xpert
Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.
Shah M; Paradis S; Betz J; Beylis N; Bharadwaj R; Caceres T; Gotuzzo E; Joloba M; Mave V; Nakiyingi L; Nicol MP; Pradhan N; King B; Armstrong D; Knecht D; Maus CE; Cooper CK; Dorman SE; Manabe YC
Clin Infect Dis; 2020 Aug; 71(5):1161-1167. PubMed ID: 31560049
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
Khalil KF; Butt T
J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
[TBL] [Abstract][Full Text] [Related]
18. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
[TBL] [Abstract][Full Text] [Related]
20. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
